Abstract
Noncompliance in patients with epilepsy is a serious hindrance to successful treatment. It can result in increased healthcare costs and put both the patients and others around them at unnecessary risk. Noncompliance should be considered whenever a patient has (1) an unexpected increase in number or severity of seizures, (2) serum levels of anticonvulsant medications below the expected range, or (3) a change in medical reimbursement systems. Effective intervention strategies are based on assessment of life-style issues and possible barriers to compliance. Communication with the patient about medication regimens and the value of treatment is extremely important, and a real partnership between physician and patient is needed to set and achieve goals.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 253-256 |
| Number of pages | 4 |
| Journal | Postgraduate Medicine |
| Volume | 88 |
| Issue number | 1 |
| DOIs | |
| State | Published - Jan 1 1990 |